Suhasini Sil on Impact of AMBM Red Cell Transfusions in Improving Transfusion Outcomes
Suhasini Sil, Senior Resident doctor at AIIMS, shared on LinkedIn:
”Proud to share our recent publication in Transfusion Medicine.
This 5-year study from our centre demonstrates how antigen-matched red cell transfusions lead to better post-transfusion outcomes in autoimmune haemolytic anaemia patients — paving the way for more personalised transfusion practices in resource-limited settings.
Explores the impact of antigen-matched best-matched (AMBM) red cell transfusions in improving transfusion outcomes.
Demonstrates that AMBM transfusions significantly reduce inter-transfusion interval (ITI) and enhance post-transfusion haemoglobin increment (PTHI) in alloimmunised AIHA patients.
Grateful to all co-authors and team members who made this possible!”
Read the full article here.
Article: Transfusion management in autoimmune haemolytic anaemia patients: A 5-year experience from a tertiary care referral centre in India.
Authors: Suhasini Sil, Vineet Sharma, Poonam Coshic, Hem Chandra Pandey, Apalak Garg, Chippy C. S., Seema Kumari Meena, Suganya Palanisamy, Vidushi Gupta
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 23, 2026, 18:19Chokri Ben Lamine: Choosing the Right LMWH in Cancer Patients
-
Apr 23, 2026, 17:57Shalini R: Not All Blood Thinners Are the Same
-
Apr 23, 2026, 17:33Abdulaziz (Omar) Badran: Navigating the Clinical Complexity of Combined Red Cell Disorders
-
Apr 23, 2026, 17:19Kate Thomas: One Hour, One Donation, One Life Saved
-
Apr 23, 2026, 17:19Ameneh Eshghinejad: The First 72 Hours After SAH Are Critical for Balancing the Risks of Rebleeding and Thromboembolism
-
Apr 23, 2026, 17:18Katarina Ziakova: The WFH Shared Decision – Making Tool Is Driving Critical Conversations in Haemophilia Care
-
Apr 23, 2026, 17:14Paulus Kirchhof: Can We Improve Prevention of Cardiovascular Diseases?
-
Apr 23, 2026, 17:08Wolfgang Miesbach: 5‑Year Gene Therapy Data from WFH Congress 2026
-
Apr 23, 2026, 17:05Veronica Sanchez: The 2026 Guideline on the Management of Dyslipidemia